'v . b6ä$Î - JPMAr Z) 2°. "@>& S T K ... u6ä$Î p F >& 4e _ > E \0ñ. "@ b ² Z b6ä$Î p F M _...
Transcript of 'v . b6ä$Î - JPMAr Z) 2°. "@>& S T K ... u6ä$Î p F >& 4e _ > E \0ñ. "@ b ² Z b6ä$Î p F M _...
2018 - 42 -
3
1
25 84
35145 14
2014 11 211121-(2)
14 3
1.1
14 3
1997 3 27 282016 1 22 9GCP
1997 3 2621 2008 6 13114 GLP
43
PMDA
8
1.2
GCP
GCP
2003
PMDA 30
2018 - 43 -
22
GCP
302003 5 15
89
PMDA
PMDA“ ” 1.4
31
2
a.2
b.
c.
d.
e.
ICH
DNAICH-M7
2016 1 15a e
DNA
201511 10 1110-(3)
2015 12 14
2018 - 44 -
2011 4 1
2013 5 31 0531-(8)
2008 4 1
2008 3 21 0321001
20142 1
2013 7 10701-(10)
1.3
1995 3 20 227 ICH-E2A
ICH 19974
A: 7
7
a)
b)
B: 1515
a)
b)
c)
d)
2008 2
ICH 2012 12 28
1611
2018 - 45 -
2012 12 281228-(1) ICH E2F
2014 10 241024-(2) 1024-(1)
1024-(9) 1024 -(15) 2016 1122 1122-(4)
1122-(10) 1122-(7)1122-(4)
1.4 PMDA
PMDA
2012 3 20302070 2018 1 4
PMDA
PMDA HPhttp://www.pmda.go.jp/review-services/f2f-pre/consultations/0007.html
I
II
II
II
I
II
II /III
2011 9 10901-(1)
20161 22 0122-(12)
0122-(2)
2018 - 46 -
OTC
GCP/GLP/GPSP
GCP/GLP/GPSP
GMP/QMS
GCTP
PMDA
GCP GLP
( II)
2018 - 47 -
GMP/GCTP/QMS
1.5
2014 11 21 1121-(2)
2014 11 21 1121-(12)PMDA HP
HPhttp://www.pmda.go.jp/review-services/drug-reviews/about-reviews/otc/0001.html
PMDA CTD
CTD2011 1 17
PMDAPMDA
GCP2 4.2
PMDA HPHP
http://www.pmda.go.jp/files/000157674.pdf
HPhttp://www.pmda.go.jp/files/000153830.pdf
PMDA
PMDAHPhttp://www.pmda.go.jp/review-services/drug-reviews/user-fees/0001.html
2015 1 309
2010 6 9
6
1
CTD
6
6
MF
MFMF
MF
2018 - 48 -
CTD 2
GMP
PMDA
2014 10 61006-(1) 1006-(1)
1.6 1996 6
GLPGCP
PMDA
2010 5 280528027
GCP2010 5 28
0528028
GCP2012 10 12
1012063
2015 4 270427-(1) 2016 10 1
GCP2016 5 11 0511005
2006 1 310131010 2014 11 21
1121-(5)
PMDAPMDA
GCP
2012 112014
3 PMDA
EDC
2013 327 0327001
EDC
PMDA
GCPGCP
2006 1 310131006 2014 11 21
1121-(1)
4
2
GCP
GCPEDC
PMDA
PMDA HP2017 3 1 PMDA
2018 - 49 -
GCP GCP
PMDA
http://www.pmda.go.jp/review-services/inspections/gcp/0002.html#r=s&r=s
1.7 GMP
GMP
GMP14 2 4
GMP
1.7.1 GMP
GMP
GMP/QMS2005 3 30
0330001GMP
A
B
C
D
GMPGMP
A
A B B
CD
GMPB
GMPGMP
GMP
1.7.2 GMPGMP GMP
GMP
MOU
EU GMPMRA 2003 5
2016 4 EU 28 MRA2016 4 26
0426-(3)
PIC/SGMP
2012 3
2018 - 50 -
PMDA PIC/S2014 7 1
PIC/S GMP 2012 2 1
2017 8 92013 8 PIC/S GMP
GMP 2005 3 300330001
2013 8 30 0830-(1)
1.7.3
1999 6 262
2005 3 31
GMP
GMP
2005 4 1
2015 122016 1
2
1999 4 8 4812004 5 25 0525003
1999 4 8666
2005 4
2005 3 31 03310152008 10 20
10200012009 3 4 0304004
2013 7 10701-(10)
2014 6 12 0612-(6)481
2005 3 310331009
2008 10 20 10200022009 3 4
03040152013 7 1
0701-(10)2014 6 12
0612-(1)
2014 11 211121-(2)
1121-(12)
ICH EUCTD
2001 6 21663
2018 - 51 -
2001 6 21899 2017 2 2
0202-(1) CTDCTD
25 1
3 5 CTD
2017 2 2
CTD eCTD
2003 6 4 06040012009 7 7
0707-(3) Version3.2.2 200910 1
Q&A
2004 5 270527004 2017 7 5
2017 7 5eCTD0705-(1)
eCTDQ&A
eCTD Version 4.0 ICH eCTD
2016 10 1eCTD
2020 3 31
25 6 14PMDA
25 6 14PMDA
2014 6 200620-(6) Q&A 2014 6 20
2015 4 27 0427-(1)Q&A 2015 4 27
Q&A2016 10 1
Clinical Data Interchange Standards Consortium
1. 1 1
(1) 1
1
(2)
(3) GLP GCP
20045 27 0527004
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
2018 - 52 -
CTD 2011 1 17
/
2017 6 23
eCTD
2. 2 2 CTD
(1) 2 2 55
(2)
(3)
(4)
(5)
(6)
(7)
3. 3 3
(1) 3 3
(2)
(3)
4. 4 4
(1) 4 4
(2)
(3)
5. 5 5(1) 5 5
(2)
(3)
(4)
10. Common Technical Document (CTD)
CTD
FD FD
MF MFMF MF
2016 10 71007001
2.1 2.1.1
2018 - 53 -
2014 11 21 1121-(2)1 2-(1) 3.
(1) (8 2) (9) (10)(10 4)
CTD8 2 10 10 4
2018 2 28
2.1.2
25 103 2014 6 12
4
2014 11 21 1121-(2)
CTD 2003 7 1
CTD
3
ICH
1998 8 11739
1998 811 672 1999 14 Q&A 2004 2 25
2006 10 5
PMDA
2007 9 280928010
2012 9 5
2014 10 27
2018 - 54 -
1999 2 1 4104
1998 3 18256 265
CTD3 3 4 4
5 5
3.1 1)
2001 5 1 568 ICH-Q6A
2001 5 1571 ICH-Q6B
ICHICH-Q6A ICH-Q6B
ICH
2009 5 260526001 ICH-Q4B
ICH
6
1998 3 111-(5)
2)
2001 5 1 565
2018 - 55 -
ICH
2003 6 3 0603001ICH-Q1A(R2)
19975 28 422 ICH-Q1B
1997 5 28 425ICH-Q1C
1998 1 66 ICH-Q5C
2002 7 31 07310042003 6 3
ICH-Q1D
1991 2 15165 43
3)
19899 11 1-(24)
ICH 7
3.
1975 3 14 113
1978 6 7 383
2012 3 230323-(1)
2010 5 27 0527-(1)
2010 6 40604-(1)
4) GLP
1997 326 21 2008 6 13
114 GLP
2001 6 21 902
GLPGLP
20086 13 0613007
8 19
2018 - 56 -
1 1-4
2 5-8
3 9 10
4 11 12
5 13 14
6 15 16
7 17 18
8 19
GLPGLP
PMDA GLP
GLP
PMDA GLP PMDAGLP GLP
2008 6 200620058 2008 8 15
0815007 2014 11 211121005 GLP
GLP
GLP
GLP
GLP
PMDA GLP
GLP 3
GLP
GLPGLP
GLP
2014 11 211121-(9) 1121-(13)
5)
8
ICH2001 6 21
902 ICH-S7AGLP
1991 1 29 42001 6
21 902
2018 - 57 -
2001 64 813
6) 9
1998 6 26 496in vitro
1996 7 2442 ICH-S3B
7
10
3.2 1)
ICH 3
1998 31998
4 21 380 ICH-E8
5.
GCP ICH
1997 3 2728 2016 1 229 GCP GCP
2018 - 58 -
2013 7 1
2)2.1
2010 2 190219-(4) ICH-M3R(R2) Q&A 2012 816(i)
(ii)
2.2)
2008 7 9GMP 0709002
GMP Q&A2009 7 2
2.3) 4 I
IV3 ICH
1998 4 21380 ICH-E8
4
5
11
11 2
2018 - 59 -
4
(i) I
I
II
2001 6 1796
2012 4 2 0402-(1)
(ii) II
II
II
III
IIII III
(iii) III
IIIIII
II
1981 7
4 2005 11 1
(iv) IV
2.4)
2.5)
(i)
(ii)
2018 - 60 -
(iii)
(iv)
In vitro in vivo1/100
GCP
2008 6 3 0603001
3)
3.1)
3.2)
3.3)
GCP
3.4)
3.5)
1996 5 1335 ICH-E3
4)
1992 3 4 20
2018 - 61 -
199811 30 1047 ICH-E9 ICH
5)
ICH ICH
11
6) GCP
GCP 198910 2 874 1990 10
1
1997 3 13
GCP 1997 327 28 1997 41
GCP2016 1 22 9GCP 6 59
3
28 1 220122-(7)
2018 - 62 -
7) GMPGCP 17 “ ”
1997 3 31 480
GMP 2008 79 0709002
GMP
GMP Q&A2009 7 2
GMP GCP
GMP
GMP
GMP2001 11 2 1200
ICH-Q7A ICH-Q7 GMP
GMP 2000 11ICH 5
20
PIC/SGMP
2012 2 1
GMPGMP
2009 3 30GMP
2009 3 300330023 GMP
44.1
DNADNA
1986 12 11 1051
2018 - 63 -
1987 5 21 434 1995 8 18769
GILSP Good Industrial Large Scale Practice 1
2 3 4
2003 6 18 97
2004 1 291
2006 6 62 2004 2 19
DNA
1984 3 30 243
1988 6 6 1 10
2017 7 5 0705-(5)
ICH
12
3-xx
4.2
200012 1
2000 12 1
2000 12 26 1314
26.4 BSE
2002 7 31
2003 5
15 2102013
BSE
26 375
4.3
2009 3 4
2018 - 64 -
0304007
ICH Q5E
Q&A2009 7 21 2010 3
31 2015 12 15
2009 3 4 03040079
2012 4 26 0426-(2)2013 4 1
4.4
1999 11 11 1651
2002 5 29 0529003
2005 4 220422001 2005 4 22 0422004
2007 11 26 11260052013 3 25 0325-(1)
PMDAHP
http://www.pmda.go.jp/PmdaSearch/iyakuSearch/ HP
2005 1 6IFPMA PhRMA
EFPIAJPMA
1
UMIN (UMIN-CTR;
http://www.umin.ac.jp/ctr/index-j.htm
http://www.japic.or.jp/index.html
2008 10 11001013 2009 4 2
4.5 ICHICH
1990 4
2018 - 65 -
6 ICHEU EFPIA MHLW JPMA FDA
PhRMA Swissmedic Health CanadaWHO IFPMA
EWG
27 10ICH
ICH 5
1EWG ICH
2a
2b
3
4 ICH5
6 ICH 70
34 5
ICH ICH HP
HPhttps://www.pmda.go.jp/int-activities/int-harmony/ich/0014.html
HP http://www.ich.org/home.html
2018 - 66 -
PMS
8
PMDA
GMP
PMDA
GVP GPSP PMDA
GPSP
1. 2. GLP3.
PMDA
GCP1. 2. 3.
2018 - 67 -
26 12
2535
31 85 83 96
9
2)
GMP
2575
2.3~2.4~2.8 5.1~5.7~6.80.5~0.6~0.7 1.2~1.5~2.0 0.7~0.9~1.6
2018 - 68 -
26 9
2512
12 34 30 31
10
2)
GMP
2575
1.6~1.9~2.0 4.2~4.4~5.60.2~0.3~0.7 1.1~1.3~1.5 0.8~0.8~1.1
2018 - 69 -
32014 11 21 1121 2 2-(1)
×
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 5 6 1 2 3 4 5 6 7
(1)
(2) ×
(3)
(4) ××× ××× × ×××××××
(5) ××× ×××××××
(6) ××× ××× ×××××××
(7) ×
(8)
(8-2) ××× ××××××× ×
(9)
(9-2) × ×××××× ××× ×
(10)
(10-2) (10)
(10-3)
(10-4) (10-3)
××× × ××× ××××××× ×1)
2018 - 70 -
3(1)
(2) (8)
(3)
(4)
(5) (7)
(6)
(7)
(8)
(9)
(10) (1) (9) 10-2 10-4DNA
1. 2. 3.
1. 2. 3.
1. 2.
3.
1. 2. 3.
1. 2. 3.
45. 6.
1. 2. 3. 4.
5. 6. 7.
2018 - 71 -
42014 11 21 1121 2 2-(2)
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 5 6 1 2 3 4 5 6 7
(1)
(2)
(3-1) ××× ××× × ×××××××
(3-2) ××× ×××××××
(3-3) ××× ××× ××× ×××××××
(4) × 2) ××× ××××× ×××
(5-1) × 2) ××× ××××× ×××
(5-2) ××× ××× ××× ××××× ×××××××
(5-3) × 2) ××× ××××× ×××××××
(5-4) ( ) ××× ××× ××× ××××× ×××××××
(6) × 2) ××× ××××× ××× ×
(7-1) × 2) ××× ××××× ××××× ×
(7-2) × 2) ××× ××××× ××××××× ×
(8) 1) × 2) ××× ×××××× ××××××× × ×
×
1) 2) 1)
2)
2018 - 72 -
4(4)
(5)
(6)
2008 3 31 0331053 .
(7)
5
(8)
1. 2. 3.
1. 2. 3.
1. 2.
3.
1. 2. 3.
1. 2. 3.
45. 6.
1. 2. 3. 4.
5. 6. 7.
2018 - 73 -
5
2018 - 74 -
6
7551995 7 20
ICH-Q2A Q2A(R1)877
1995 9 25
1204001 2006 12 4
ICH-Q3A Q3A(R2)539
1997 6 23
0703004 2006 7 3ICH-Q3B Q3B(R2)
3381997 10 28
ICH-Q2B Q2(R1)307
1998 3 30
0211-(1) 2011 2 21ICH-Q3C Q3C (R5)
0930-(4)2015 9 30
ICH-Q3D568
2001 5 1ICH-Q6A
5712001 5 1
ICH-Q6B574
2001 5 1
09010012006 9 1
0628-(1) 2010 6 28ICH-Q8
0616-(1)2011 6 16
0710-(9)2014 7 10
ICH-Q11DNA 1110 –(3)
2015 11 10ICH-M7
2018 - 75 -
7
881993 8 10
ICH-S4443
1996 7 2ICH-S3A
5441996 8 6
ICH-S1C551
1998 7 9ICH-S1C(R) S1C(R1)
3151997 14
ICH-S1A316
1997 4 14ICH-S5A/ICH-S5B
18342000 12 27ICH-S5B(M) S5(R2)
5481998 7 9
ICH-S1B1019
1998 11 13
18312000 12 27
0219-(4) 2010 2 19ICH-M3(M) M3(R2)
Q&A 2012 8 16
16041999 11 1
ICH-S21607
1999 11 1
1127001 2008 11 27
04180012006 4 18
ICH-S8QT 1023-(4)
2009 10 23ICH-S7B
2018 - 76 -
0920-(2)2012 9 20
ICH-S2 (R1)1002-(5)
2012 10 2
0521-(1)2014 5 21
ICH-S10
8
41991 1 29
9022001 6 21
ICH-S7A813
2001 6 4
9
4961998 6 26
4421996 7 2
ICH-S3B
0711-(1)2013 7 11
Q&A 2013 7 110401-(1)
2014 4 1
Q&A 2014 4 1
8132001 6 4
2014 7 8
2018 - 77 -
10
0229-(10)2012 2 29
0229-(10)2012 2 29
0229-(10)2012 2 29
0229-(10)2012 2 29
11240042006 11 24
11240012006 11 24
1101 -(1)2010 11 1
Q&A 2013 4 19
2016 3 11
2016 3 11
11
11-(10)
1987 4 211-(22)1987 10 31
1(1)1988 1 5
1(7)1988 3 16
7431998 8 25
2010 8 3742
1999 4 152017 7 70707-(1)
01280012002 1 28
ICH-E12A ICH-E120325035
2004 3 250512001
2004 5 121101001
2018 - 78 -
2005 11 12005 11 2
02170012006 2 17
06280012006 6 28
0527-(5)2010 5 27
0709-(1)2010 7 9
2014 5 191116-(1)
2010 11 160329 -(18)
2011 3 290930-(1)
2011 9 301213-(1)
2011 12 130930-(1)
2015 9 300407-(1)
2016 4 72
1041993 12 2
ICH-E7 (2010 9 17Q&A
2010 9 17
4941994 7 25
ICH-E4592
1995 5 24ICH-E1
3351996 5 1
ICH-E3380
1998 4 21ICH-E8
6721998 8 11
ICH-E5 ICH-E5(R1)2004 2 25
Q&A 2006 10 5Q&A 2
10471998 11 30
2018 - 79 -
ICH-E91334
2000 12 15ICH-E11
1362001 2 27
ICH-E10 20014 10
06030012008 6 3
QT/QTc 1023-(1)2009 10 23
ICH-E14 2009 10 23Q&A 2012
7 3 Q&A2
0219-(4)2010 2 19
ICH-M3(R2) 2012 816 Q&A
311(4) 198015(2) 198415(6) 198416(3) 1985
1-(5)1988 3 11
1031-(1)2011 10 31
0611-(1)2012 6 11
0701-(10)2013 7 1
2013 12 26PK PD 1225-(10)
2015 12 250328-(19)
2016 3 28siRNA
2016 3 28
2018 - 80 -
12
3292000 2 22
ICH-Q5ADNA 3
1998 1 6ICH-Q5B
) 61998 1 6
ICH-Q5C( ) 873
2000 7 14ICH-Q5D
) 04260012005 4 26
ICH-Q5E571
2001 5 1ICH-Q6B
0323-(1)2012 3 23
ICH-S6(R)0701-(4)
2013 7 1
0701-(7)2013 7 1
2018 - 81 -
11 Common Technical Document (CTD)
2018 - 82 -
12
2018 - 83 -
Quality Safety Efficacy Multidisciplinary
Step 5
Q1A(R2)Q1BQ1CQ1DQ1EQ2(R1)Q3A(R2)Q3B(R2)Q3C(R5)Q3DQ4BQ4B(Annex1)(R1)Q4B(Annex2)(R1)Q4B(Annex3)(R1)Q4B(Annex4A, 4B, 4C) (R1)
Q4B(Annex6)(R1)Q4B(Annex5)(R1)Q4B(Annex7)(R2)Q4B(Annex8)(R1)Q4B(Annex9)(R1)Q4B(Annex10)(R1)Q4B(Annex11)Q4B(Annex12)Q4B(Annex13)Q4B(Annex14)Q5A(R1)Q5BQ5CQ5DQ5EQ6A
Q6BQ7Q8(R2)Q9Q10Q11
&
&
ICH
/ 3
GMP
S1AS1BS1C(R2)S2(R1)S3A
S3BS4S5(R2)S6(R1)S7AS7BS8S9S10
QT
E1
E2A
E2B(R2)E2B(R3)
E2C(R2)E2DE2EE2FE3E4E5(R1)E6(R1)E7E8E9E10E11E12E14
E15E16
(ICSR)
(PBRER)
(PvP)(DSUR)
QT/QTc
M1M2M3(R2)M4M4E(R2)M7
M8M8
ICH (MedDRA)
CTDDNA
v.3.2.2v.4.0
Step 4
Q3C(R6) E6(R2)E11(R1)E17E18
M7(R1) DNA
Step 3 S5(R3) E9(R1)
Step 2a/2b Q12
Step 1
Step 1Q3C(R7) S1
S11E19E8(R1)E11A
M9M10
BCS
1 Step1 Step 2a/2b /Step 3 Step 4 Step 5
2 Q&A
13 ICH 2017 11 17
http://www.pmda.go.jp/files/000221387.pdf